Siga Technologies (SIGA) Tax Provisions (2010 - 2025)
Siga Technologies' (SIGA) quarterly Tax Provisions came in at -$2.0 million in Q3 2025, down 476.45% on a YoY basis from $528647.0 in Q3 2024, and down 116.86% quarter-over-quarter from $11.8 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Tax Provisions (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Tax Provisions for 16 consecutive years, with -$2.0 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Tax Provisions fell 476.45% year-over-year to -$2.0 million; the trailing twelve-month figure through Sep 2025 stood at $22.4 million (down 23.91% YoY), and the FY2024 full-year result was $16.9 million, down 31.21% from the prior year.
- Tax Provisions declined to -$2.0 million in Q3 2025 per SIGA's latest filing, from $11.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $25.4 million in Q4 2023 and bottomed at -$2.0 million in Q3 2025.
- Historically, Tax Provisions has averaged $4.5 million across 5 years, with a median of $528647.0 in 2024.
- The widest YoY moves for Tax Provisions: up 1866.67% in 2025, down 476.45% in 2025.
- Over 5 years, Tax Provisions stood at $20.7 million in 2021, then slumped by 83.01% to $3.5 million in 2022, then surged by 623.5% to $25.4 million in 2023, then sank by 49.54% to $12.8 million in 2024, then tumbled by 115.52% to -$2.0 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$2.0 million, $11.8 million, and -$200000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -407.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -524.23 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 165.91 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 39.70 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | 11.80 Mn |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 528,647.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 2.94 Mn |
| Dec 31, 2023 | 25.41 Mn |
| Sep 30, 2023 | -33,030.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | -300,000.00 |
| Dec 31, 2022 | 3.51 Mn |
| Sep 30, 2022 | 10.10 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -703,406.00 |
| Dec 31, 2021 | 20.67 Mn |
| Sep 30, 2021 | -900,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | -232,933.00 |
| Dec 31, 2020 | 6.07 Mn |